• Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Telegram
  • Koo
  • Youtube
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ

Tag: Covovax

A man receives a dose of COVID-19 vaccine at Paulista Avenue in Sao Paulo, Brazil on July 25, 2021.
NTAGI approves Serum Institute's Covovax for 12-17 age group

India's drug regulator, the Drugs Controller General of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12-17 age group with certain conditions on March 9.

Govt Panel Recommends EUA For COVID-19 Vaccines Covovax, Corbevax, Anti-Covid Pill Molnupiravir
DCGI's EUA Nod To Covovax For 12-17 Yrs Age Group

The government has still not not taken a decision on vaccinating those aged below 15 years. The health ministry has consistently said that additional need for vaccination and inclusion of population for vaccination are examined constantly.

Covovax Receives WHO Approval For Emergency Use
Covid: Govt Panel Recommends Permission For Phase-3 Trial Of Covovax As Booster Dose In Adults

The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation had on Friday recommended giving permission for conducting a phase-3 clinical trial of the single-dose COVID-19 vaccine Sputnik Light as a booster dose.

Serum Institute Seeks EUA For Its Covovax Vaccine For 12-17 Yrs Age Group
Serum Institute Seeks EUA For Its Covovax Vaccine For 12-17 Yrs Age Group

The Drugs Controller General Of India has already approved Covovax for restricted use in emergency situations in adults on December 28.

India-US Healthcare Collaboration In Spotlight As India Approves 2 More Covid Vaccines
India-US Healthcare Collaboration In Spotlight As India Approves 2 More Covid Vaccines

"This announcement is an important first step in vaccinating the world and halting the pandemic. Our vaccine technology offers a path to address an unfolding humanitarian crisis, namely the vulnerability the low- and middle-income countries face against the delta variant, Hotez said.

COVID Vaccine
Govt Panel Recommends EUA For COVID-19 Vaccines Covovax, Corbevax And Anti-Covid Pill Molnupiravir

All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.

Serum Institute
Serum Institute Manufacturing First Batch Of Covovax COVID-19 Vaccine

The Centre said that more than 30.54 crore vaccine doses have been provided to the states and Union Territories so far. According to the health ministry, 1,50,28,186 Covid doses are still available with the states and Union Territories to be administered.

scrollToTop